HomeUSAJ.P. Morgan Life Sciences Private Capital Adds Dashyant Dhanak, Ph.D. as Venture...

J.P. Morgan Life Sciences Private Capital Adds Dashyant Dhanak, Ph.D. as Venture Partner

-

Dashyant Dhanak
Dashyant (Dash) Dhanak, Ph.D.

J.P. Morgan Life Sciences Private Capital, the NYC-based life sciences venture and growth equity arm within J.P. Morgan Asset Management, announced the appointment of Dashyant Dhanak, Ph.D., as Venture Partner.

Dr. Dhanak is a seasoned pharmaceutical research and development expert with over 30 years of experience. Most recently, he was the Chief Scientific Officer at Deciphera Pharmaceuticals, which was acquired by Ono Pharmaceuticals in 2024. Prior to his role at Deciphera, Dr. Dhanak served as Chief Scientific Officer at Incyte, where he was responsible for overseeing the research and preclinical development of innovative medicines across the company’s hematology, oncology, and immunology franchises. During his tenure at Incyte, Dr. Dhanak contributed significantly to the filing of over fifteen Investigational New Drug (IND) applications. Before joining Incyte in 2018, he was Vice President and Global Head of Discovery Sciences at Johnson & Johnson’s (J&J) Janssen Research & Development group. Prior to J&J, he spent 25 years at GlaxoSmithKline.

J.P. Morgan Life Sciences Private Capital is the life sciences platform of J.P. Morgan Private Capital, the investment arm for private companies across the capital structure with a focus on venture and growth investing within J.P. Morgan Asset Management. The firm partners with early-stage biotherapeutics and late-stage healthcare companies. 

FinSMEs

19/05/2025

THE DAILY NEWSLETTER - SIGNUP